title: Antidiabetic agents: a new class of reversible carnitine palmitoyltransferase I inhibitors.
authors.affiliation: Diabetes Department, Sandoz Research Institute, Sandoz Pharmaceuticals Corporation, East Hanover, New Jersey 07936, USA.
authors.forename: R C
authors.initials: RC
authors.lastname: Anderson
authors.forename: M
authors.initials: M
authors.lastname: Balestra
authors.forename: P A
authors.initials: PA
authors.lastname: Bell
authors.forename: R O
authors.initials: RO
authors.lastname: Deems
authors.forename: W S
authors.initials: WS
authors.lastname: Fillers
authors.forename: J E
authors.initials: JE
authors.lastname: Foley
authors.forename: J D
authors.initials: JD
authors.lastname: Fraser
authors.forename: W R
authors.initials: WR
authors.lastname: Mann
authors.forename: M
authors.initials: M
authors.lastname: Rudin
authors.forename: E B
authors.initials: EB
authors.lastname: Villhauer
mesh_terms: D020155:3-Hydroxybutyric Acid; D000284:Administration, Oral; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D002334:Carnitine O-Palmitoyltransferase / Q000037:antagonists & inhibitors*; D002478:Cells, Cultured; D015195:Drug Design; D005227:Fatty Acids / Q000378:metabolism; D006885:Hydroxybutyrates / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000737:chemistry / Q000145:classification / Q000494:pharmacology*; D008099:Liver / Q000201:enzymology; D063065:Organophosphonates / Q000737:chemistry / Q000494:pharmacology*; D010084:Oxidation-Reduction; D051381:Rats; D013329:Structure-Activity Relationship
chemical_list: D001786:Blood Glucose; D005227:Fatty Acids; D006885:Hydroxybutyrates; D007004:Hypoglycemic Agents; D063065:Organophosphonates; D002334:Carnitine O-Palmitoyltransferase; D020155:3-Hydroxybutyric Acid